• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GAD1表达及其甲基化作为胸腺上皮肿瘤恶性行为的指标

GAD1 expression and its methylation as indicators of malignant behavior in thymic epithelial tumors.

作者信息

Soejima Shiho, Kondo Kazuya, Tsuboi Mitsuhiro, Muguruma Kyoka, Tegshee Bilguun, Kawakami Yukikiyo, Kajiura Koichiro, Kawakita Naoya, Toba Hiroaki, Yoshida Mitsuteru, Takizawa Hiromitsu, Tangoku Akira

机构信息

Department of Oncological Medical Services, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8509, Japan.

Department of Thoracic, Endocrine Surgery and Oncology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8503, Japan.

出版信息

Oncol Lett. 2021 Jun;21(6):483. doi: 10.3892/ol.2021.12744. Epub 2021 Apr 21.

DOI:10.3892/ol.2021.12744
PMID:33968199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8100960/
Abstract

Thymic epithelial tumors (TETs) comprise thymomas and thymic carcinoma (TC). TC has more aggressive features and a poorer prognosis than thymomas. Genetic and epigenetic alterations in thymomas and TC have been investigated in an attempt to identify novel target molecules for TC. In the present study, genome-wide screening was performed on aberrantly methylated CpG islands in thymomas and TC, and the glutamate decarboxylase 1 gene () was identified as the 4th significantly hypermethylated CpG island in TC compared with thymomas. catalyzes the production of γ-aminobutyric acid from L-glutamic acid. expression is abundant in the brain but rare in other tissues, including the thymus. A total of 73 thymomas and 17 TC tissues were obtained from 90 patients who underwent surgery or biopsy at Tokushima University Hospital between 1990 and 2017. DNA methylation was examined by bisulfite pyrosequencing, and the mRNA and protein expression levels of were analyzed using reverse transcription-quantitative PCR and immunohistochemistry, respectively. The DNA methylation levels of were significantly higher in TC tissues than in the normal thymus and thymoma tissues, and methylation exhibited high sensitivity and specificity for discriminating between TC and thymoma. The mRNA and protein expression levels of were significantly higher in TC tissues than in thymomas. Patients with TET with high DNA hypermethylation and high mRNA and protein expression levels had significantly shorter relapse-free survival rates than those with low levels. In conclusion, significantly more epigenetic alterations were observed in TC tissues compared with in thymomas, which may contribute to the clinical features and prognosis of patients.

摘要

胸腺上皮肿瘤(TETs)包括胸腺瘤和胸腺癌(TC)。与胸腺瘤相比,胸腺癌具有更具侵袭性的特征和更差的预后。人们对胸腺瘤和胸腺癌中的基因和表观遗传改变进行了研究,试图确定胸腺癌的新靶点分子。在本研究中,对胸腺瘤和胸腺癌中异常甲基化的CpG岛进行了全基因组筛选,谷氨酸脱羧酶1基因()被确定为与胸腺瘤相比在胸腺癌中第4个显著高甲基化的CpG岛。催化从L-谷氨酸产生γ-氨基丁酸。在大脑中表达丰富,但在包括胸腺在内的其他组织中很少见。1990年至2017年期间,从德岛大学医院接受手术或活检的90例患者中获取了73例胸腺瘤和17例胸腺癌组织。通过亚硫酸氢盐焦磷酸测序检测DNA甲基化,并分别使用逆转录定量PCR和免疫组织化学分析的mRNA和蛋白表达水平。胸腺癌组织中的DNA甲基化水平显著高于正常胸腺和胸腺瘤组织,甲基化对区分胸腺癌和胸腺瘤具有高敏感性和特异性。胸腺癌组织中的mRNA和蛋白表达水平显著高于胸腺瘤。DNA高甲基化以及mRNA和蛋白表达水平高的胸腺上皮肿瘤患者的无复发生存率显著低于水平低的患者。总之,与胸腺瘤相比,在胸腺癌组织中观察到明显更多的表观遗传改变,这可能有助于患者的临床特征和预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e78/8100960/a63810bb66cc/ol-21-06-12744-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e78/8100960/899e955c3073/ol-21-06-12744-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e78/8100960/6f83262621a2/ol-21-06-12744-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e78/8100960/a63810bb66cc/ol-21-06-12744-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e78/8100960/899e955c3073/ol-21-06-12744-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e78/8100960/6f83262621a2/ol-21-06-12744-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e78/8100960/a63810bb66cc/ol-21-06-12744-g02.jpg

相似文献

1
GAD1 expression and its methylation as indicators of malignant behavior in thymic epithelial tumors.GAD1表达及其甲基化作为胸腺上皮肿瘤恶性行为的指标
Oncol Lett. 2021 Jun;21(6):483. doi: 10.3892/ol.2021.12744. Epub 2021 Apr 21.
2
Aberrant DNA Methylation of NPTX2 as an Indicator of Malignant Behavior in Thymic Epithelial Tumors.NPTX2基因异常甲基化作为胸腺上皮肿瘤恶性行为的指标
Cancers (Basel). 2024 Jan 11;16(2):329. doi: 10.3390/cancers16020329.
3
DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common epigenetic alteration in thymic carcinoma.甘丙肽受体(GHSR)、G 蛋白亚基 γ 4(GNG4)、同源盒基因 D9(HOXD9)和 SALL3 的 DNA 甲基化是胸腺癌中常见的表观遗传改变。
Int J Oncol. 2020 Jan;56(1):315-326. doi: 10.3892/ijo.2019.4915. Epub 2019 Nov 18.
4
Frequent silencing of RASSF1A by DNA methylation in thymic neuroendocrine tumours.在胸腺神经内分泌肿瘤中,RASSF1A常因DNA甲基化而沉默。
Lung Cancer. 2017 Sep;111:116-123. doi: 10.1016/j.lungcan.2017.05.019. Epub 2017 May 25.
5
Circuit- and Diagnosis-Specific DNA Methylation Changes at γ-Aminobutyric Acid-Related Genes in Postmortem Human Hippocampus in Schizophrenia and Bipolar Disorder.精神分裂症和双相情感障碍患者死后海马体中γ-氨基丁酸相关基因的与电路和诊断特异性的 DNA 甲基化变化。
JAMA Psychiatry. 2015 Jun;72(6):541-51. doi: 10.1001/jamapsychiatry.2015.49.
6
Programmed death-ligand 1 expression profiling in thymic epithelial cell tumors: Clinicopathological features and quantitative digital image analyses.程序性死亡配体1在胸腺上皮细胞瘤中的表达谱分析:临床病理特征及定量数字图像分析
Lung Cancer. 2020 Jul;145:40-47. doi: 10.1016/j.lungcan.2020.04.038. Epub 2020 May 6.
7
Prognostic significance of GAD1 overexpression in patients with resected lung adenocarcinoma.GAD1 过表达对肺腺癌患者术后的预后意义。
Cancer Med. 2019 Aug;8(9):4189-4199. doi: 10.1002/cam4.2345. Epub 2019 Jun 17.
8
Transcriptomic and Mutational Analysis Discovering Distinct Molecular Characteristics Among Chinese Thymic Epithelial Tumor Patients.转录组学和突变分析揭示中国胸腺上皮肿瘤患者的不同分子特征
Front Oncol. 2021 Sep 8;11:647512. doi: 10.3389/fonc.2021.647512. eCollection 2021.
9
Genomic characterization of thymic epithelial tumors reveals critical genes underlying tumorigenesis and poor prognosis.胸腺上皮肿瘤的基因组特征揭示了肿瘤发生和预后不良的关键基因。
Clin Genet. 2023 May;103(5):529-539. doi: 10.1111/cge.14285. Epub 2023 Jan 1.
10
The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma.胸腺瘤和胸腺癌中胸内胚层标记物表达的临床病理意义。
BMC Cancer. 2023 Feb 16;23(1):161. doi: 10.1186/s12885-023-10619-6.

引用本文的文献

1
A GAD1 inhibitor suppresses osteosarcoma growth through the Wnt/β-catenin signaling pathway.一种GAD1抑制剂通过Wnt/β-连环蛋白信号通路抑制骨肉瘤生长。
Heliyon. 2024 May 17;10(10):e31444. doi: 10.1016/j.heliyon.2024.e31444. eCollection 2024 May 30.
2
Aberrant DNA Methylation of NPTX2 as an Indicator of Malignant Behavior in Thymic Epithelial Tumors.NPTX2基因异常甲基化作为胸腺上皮肿瘤恶性行为的指标
Cancers (Basel). 2024 Jan 11;16(2):329. doi: 10.3390/cancers16020329.
3
miR-4284 Functions as a Tumor Suppressor in Renal Cell Carcinoma Cells by Targeting Glutamate Decarboxylase 1.

本文引用的文献

1
Expression of molecules of the Wnt pathway and of E-cadherin in the etiopathogenesis of human thymomas.Wnt信号通路分子及E-钙黏蛋白在人类胸腺瘤发病机制中的表达
Oncol Lett. 2020 Mar;19(3):2413-2421. doi: 10.3892/ol.2020.11343. Epub 2020 Jan 23.
2
DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common epigenetic alteration in thymic carcinoma.甘丙肽受体(GHSR)、G 蛋白亚基 γ 4(GNG4)、同源盒基因 D9(HOXD9)和 SALL3 的 DNA 甲基化是胸腺癌中常见的表观遗传改变。
Int J Oncol. 2020 Jan;56(1):315-326. doi: 10.3892/ijo.2019.4915. Epub 2019 Nov 18.
3
Prognostic significance of GAD1 overexpression in patients with resected lung adenocarcinoma.
微小RNA-4284通过靶向谷氨酸脱羧酶1在肾癌细胞中发挥肿瘤抑制作用。
Cancers (Basel). 2023 Jul 30;15(15):3888. doi: 10.3390/cancers15153888.
4
Insights into the leveraging of GABAergic signaling in cancer therapy.深入了解 GABA 能信号在癌症治疗中的应用。
Cancer Med. 2023 Jul;12(13):14498-14510. doi: 10.1002/cam4.6102. Epub 2023 May 18.
5
Epigenetics of Thymic Epithelial Tumors.胸腺上皮肿瘤的表观遗传学
Cancers (Basel). 2023 Jan 5;15(2):360. doi: 10.3390/cancers15020360.
6
Promotor methylation status of MAPK4 is a novel epigenetic biomarker for prognosis of recurrence in patients with thymic epithelial tumors.MAPK4 的启动子甲基化状态是胸腺瘤患者复发预后的新型表观遗传生物标志物。
Thorac Cancer. 2022 Oct;13(20):2844-2853. doi: 10.1111/1759-7714.14628. Epub 2022 Sep 8.
7
Thymic Epithelial Neoplasms: Focusing on the Epigenetic Alterations.胸腺上皮肿瘤:关注表观遗传学改变。
Int J Mol Sci. 2022 Apr 6;23(7):4045. doi: 10.3390/ijms23074045.
8
Thymic Carcinomas-A Concise Multidisciplinary Update on Recent Developments From the Thymic Carcinoma Working Group of the International Thymic Malignancy Interest Group.胸腺癌——国际胸腺癌兴趣小组胸腺癌工作组对近期进展的简要多学科更新。
J Thorac Oncol. 2022 May;17(5):637-650. doi: 10.1016/j.jtho.2022.01.021. Epub 2022 Feb 25.
GAD1 过表达对肺腺癌患者术后的预后意义。
Cancer Med. 2019 Aug;8(9):4189-4199. doi: 10.1002/cam4.2345. Epub 2019 Jun 17.
4
The role of targeted therapy in thymic carcinoma.靶向治疗在胸腺癌中的作用。
J Oncol Pharm Pract. 2019 Oct;25(7):1712-1718. doi: 10.1177/1078155219852758. Epub 2019 Jun 4.
5
Systemic treatments for thymoma and thymic carcinoma: A systematic review.胸腺瘤和胸腺癌的系统治疗:系统评价。
Lung Cancer. 2018 Dec;126:25-31. doi: 10.1016/j.lungcan.2018.10.018. Epub 2018 Oct 18.
6
The Integrated Genomic Landscape of Thymic Epithelial Tumors.胸腺癌的综合基因组景观。
Cancer Cell. 2018 Feb 12;33(2):244-258.e10. doi: 10.1016/j.ccell.2018.01.003.
7
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study.派姆单抗治疗胸腺癌患者的单臂、单中心、2 期研究。
Lancet Oncol. 2018 Mar;19(3):347-355. doi: 10.1016/S1470-2045(18)30062-7. Epub 2018 Jan 26.
8
The genomic and epigenomic landscape in thymic carcinoma.胸腺癌的基因组和表观基因组格局
Carcinogenesis. 2017 Oct 26;38(11):1084-1091. doi: 10.1093/carcin/bgx094.
9
Frequent silencing of RASSF1A by DNA methylation in thymic neuroendocrine tumours.在胸腺神经内分泌肿瘤中,RASSF1A常因DNA甲基化而沉默。
Lung Cancer. 2017 Sep;111:116-123. doi: 10.1016/j.lungcan.2017.05.019. Epub 2017 May 25.
10
Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.胸腺瘤和胸腺癌的分子剖析:基因差异与潜在的新型治疗靶点
Pathol Oncol Res. 2017 Jul;23(3):551-564. doi: 10.1007/s12253-016-0144-8. Epub 2016 Nov 14.